首页> 美国卫生研究院文献>Immunology >Identification and partial purification of human T lymphocyte colony-enhancing factor (LCEF) distinct from T cell-growth factor.
【2h】

Identification and partial purification of human T lymphocyte colony-enhancing factor (LCEF) distinct from T cell-growth factor.

机译:与T细胞生长因子不同的人T淋巴细胞集落增强因子(LCEF)的鉴定和部分纯化。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Colony growth of T lymphocytes in a soft agar culture system, following stimulation with phytohaemagglutinin (PHA), is enhanced by T cell-derived conditioned medium (CM). The putative enhancing factor present in this CM has been termed lymphocyte colony-enhancing factor (LCEF). The purification of LCEF from CM has been complicated by the fact that active CM could be obtained only in the presence of 7-8 mg/ml of serum proteins. In order to circumvent this problem, CM which was shown to be active in the colony formation assay, was produced in the presence of a serum fraction precipitated by 1.6 M ammonium sulphate (AS). The first step of the purification of this CM was fractionation by 1.6 M AS, whereby the active material was fully recovered in the supernatant. The 20-fold purified material was applied on a DEAE-cellulose column. Two peaks of activity were obtained using the colony formation assay. The purification achieved by this second step was 5-10 fold for the first peak, eluting around 0.06 M NaCl, and two- to three-fold for the second peak, eluting around 0.19 M NaCl. Two peaks of activity were also obtained upon hydrophobic chromatography on a phenyl-Sepharose column, with enhancement factors of 5-8 for the first peak and 25-60 for the second peak. These results imply the presence of more than one LCEF molecule in the original CM. None of the LCEF-active fractions contained any T cell-growth factor (TCGF) activity; LCEF seems therefore to be a molecular entity distinct from TCGF.
机译:T细胞来源的条件培养基(CM)增强了植物血凝素(PHA)刺激后,软琼脂培养系统中T淋巴细胞的菌落生长。存在于该CM中的推定增强因子已被称为淋巴细胞集落增强因子(LCEF)。由于只有在7-8 mg / ml血清蛋白存在下才能获得活性CM,因此从CM纯化LCEF变得很复杂。为了解决该问题,在存在由1.6 M硫酸铵(AS)沉淀的血清级分的情况下,生产出在菌落形成试验中具有活性的CM。纯化该CM的第一步是通过1.6 M AS分级分离,由此活性物质在上清液中被完全回收。将20倍纯化的材料施加在DEAE-纤维素柱上。使用菌落形成测定法获得了两个活性峰。通过第二步得到的纯化结果是,第一个峰的洗脱峰高为5-10倍,洗脱约0.06 M NaCl,第二个峰的纯化峰洗脱为两倍至三倍,约0.19 M NaCl洗脱。在苯基-Sepharose柱上进行疏水色谱分析时,还获得了两个活性峰,第一个峰的增强因子为5-8,第二个峰的增强因子为25-60。这些结果暗示在原始CM中存在不止一个LCEF分子。 LCEF活性级分均不包含任何T细胞生长因子(TCGF)活性。因此,LCEF似乎是不同于TCGF的分子实体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号